Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349411 · ClinicalTrials.gov registry record
Spatial Neglect and Delirium After Stroke
A clinical trial, sponsored by Kessler Foundation.
- Completed
- Registry status
- 45
- Enrollment target
NCT03349411: Completed study, sponsored by Kessler Foundation.
NCT03349411 is a clinical trial that has completed, run by Kessler Foundation. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03349411 has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The goal of this study is to understand what brain mechanisms become disrupted when stroke survivors experience delirium. Delirium is an acute reduction in attention and cognition, associated with poor recovery, longer hospitalization and even death. One major factor increasing the risk of delirium after stroke may be spatial neglect occurring after stroke on the right side of the brain. Spatial neglect affects awareness, orientation, and movement. The study will test the hypothesis that the right-dominant brain networks for arousal and attention are affected in both of these disorders. It is expected that the activity and structural integrity of these brain networks will correlate with behavioral signs and severity of delirium and spatial neglect. To test this hypothesis, the study will measure spatial neglect and delirium symptoms in 45 acute (NYC Health + Hospitals/Bellevue ) and 30 subacute (Kessler Institute for Rehabilitation) stroke survivors and evaluate brain scans for these participants. This study may contribute to knowledge about brain bio-markers of delirium, which will greatly aid in delirium detection in stroke and other disorders.
Primary Outcome
functional connectivity
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging
- DIAGNOSTIC_TEST Confusion Assessment Method
- DIAGNOSTIC_TEST Behavioral Inattention Test
- DIAGNOSTIC_TEST Florida Mental Status Examination
- DIAGNOSTIC_TEST Montreal Cognitive Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2020-12-30 |
What the finished NCT03349411 record still lists
NCT03349411 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT03349411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03349411 about?
NCT03349411 is a clinical study titled "Spatial Neglect and Delirium After Stroke". The goal of this study is to understand what brain mechanisms become disrupted when stroke survivors experience delirium. Delirium is an acute reduction in attention and cognition, associated with poor recovery, longer hospitalization and even death. One major factor increasing the risk of delirium ...
What is the current status of trial NCT03349411?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2017-07-18. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT03349411?
The interventions under investigation include: Magnetic Resonance Imaging (DIAGNOSTIC_TEST), Confusion Assessment Method (DIAGNOSTIC_TEST), Behavioral Inattention Test (DIAGNOSTIC_TEST), Florida Mental Status Examination (DIAGNOSTIC_TEST), Montreal Cognitive Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03349411?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI